Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-08

Clinical Trial Update: A Drug Interaction Study of Simvastatin and Albiglutide [Phase 1]

View source ↗

Summary

This Clinical Trial Update documents a Phase 1 drug interaction study between simvastatin and albiglutide in individuals with type 2 diabetes. The trial status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albiglutide (albiglutide)
  • SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED